128 Participants Needed

Care Partner Assessment Tool for Dementia

AM
Overseen ByAnne Mortensen
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Wisconsin, Madison
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to see whether an adapted questionnaire called the Care Partner Hospital Assessment Tool (CHAT) for care partners of hospitalized patients living with Alzheimer's disease and related dementias (ADRD) (CHAT-AD) can help people with dementia receive better care after they go home from the hospital. Participants will be a care partner ('family member or friend') who provides unpaid care to a hospitalized adult relative or partner to help them take care of themselves because of dementia. Participants can expect to be in this study for 14 days.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

Is the Care Partner Assessment Tool for Dementia safe for use in humans?

The Care Partner Assessment Tool, also known as CHAT, has been evaluated for its feasibility and appropriateness in hospital settings, but there is no specific safety data available for its use in humans. It is designed to help identify and address the needs of care partners, but it does not involve any direct medical treatment or intervention.12345

How does the Care Partner Assessment Tool for Dementia differ from other treatments for dementia?

The Care Partner Assessment Tool for Dementia is unique because it focuses on identifying and preparing care partners (family members or friends) of people with dementia during hospitalization, rather than directly treating the dementia itself. This tool helps ensure that care partners are equipped with the necessary skills and information to support their loved ones, which is a novel approach compared to traditional treatments that primarily target the symptoms of dementia.13456

What data supports the effectiveness of the treatment Care Partner Hospital Assessment Tool (CHAT) for dementia?

The CHAT has been shown to be a feasible and appropriate tool for identifying the needs of care partners of hospitalized older adults, which can help tailor education and skills training to better prepare them for caregiving responsibilities. Although it has not yet been specifically tested for dementia care, its design and validation suggest it could be beneficial in this context.12345

Who Is on the Research Team?

BF

Beth Fields, PhD

Principal Investigator

University of Wisconsin, Madison

Are You a Good Fit for This Trial?

This trial is for adult care partners who provide unpaid assistance to a hospitalized relative or partner with Alzheimer's disease or related dementias (ADRD). Participants must be over 18 and speak English. It's not suitable for those who cannot communicate in English.

Inclusion Criteria

I am an unpaid caregiver for a relative or partner with ADRD in the hospital.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Adaptation and Co-design

Adaptation of CHAT-AD through co-design sessions with stakeholders

4 months
5 co-design videoconference sessions

Recruitment and Randomization

Recruitment of care partners and randomization into intervention or control groups

2-4 weeks

Intervention

Participants receive either the adapted CHAT-AD intervention or standard care

14 days

Follow-up

Participants are monitored for outcomes such as care partner satisfaction and burden

72 hours post-discharge

What Are the Treatments Tested in This Trial?

Interventions

  • Care Partner Hospital Assessment Tool
Trial Overview The study is testing the CHAT-AD, an assessment tool designed to improve post-hospital care for people with dementia. Care partners will use this questionnaire to help ensure better ongoing care once the patient returns home from the hospital.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Adjusted CHAT-ADExperimental Treatment1 Intervention
Group II: Standard of CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Wisconsin, Madison

Lead Sponsor

Trials
1,249
Recruited
3,255,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Published Research Related to This Trial

The Care Partner Hospital Assessment Tool (CHAT) is being adapted for use with care partners of hospitalized individuals living with dementia, aiming to enhance their preparedness for caregiving after discharge.
A pilot randomized controlled trial will evaluate the feasibility and effectiveness of the adapted tool (D-CHAT) over approximately 60 months, with the goal of improving hospital care processes and outcomes for both patients and their care partners.
Adapting and Testing the Care Partner Hospital Assessment Tool for Use in Dementia Care: Protocol for a 2 Sequential Phase Study.Fields, B., Werner, N., Shah, MN., et al.[2023]
The implementation of a clinician-carer communication tool, known as TOP 5, over 12 months in 21 Australian hospitals significantly increased clinician confidence in caring for patients with dementia, as reported by 798 clinicians.
While there was no overall change in incident-reported falls across all hospitals, one hospital with a matched control ward saw an average reduction of 6.85 falls per month in the intervention ward, suggesting potential improvements in patient safety.
Improving clinician-carer communication for safer hospital care: a study of the 'TOP 5' strategy in patients with dementia.Luxford, K., Axam, A., Hasnip, F., et al.[2022]
The Care Partner Hospital Assessment Tool (CHAT) was found to be easy to understand and complete by care partners of hospitalized older adults, indicating its feasibility for use in clinical settings.
Care partners reported that the CHAT was useful in identifying their needs and those of the older adults they care for, supporting its face validity and acceptability for improving care partner support in hospitals.
Evaluation of Face Validity and Acceptability of the Care Partner Hospital Assessment Tool.Fields, B., Carbery, M., Schulz, R., et al.[2023]

Citations

Adapting and Testing the Care Partner Hospital Assessment Tool for Use in Dementia Care: Protocol for a 2 Sequential Phase Study. [2023]
Improving clinician-carer communication for safer hospital care: a study of the 'TOP 5' strategy in patients with dementia. [2022]
Evaluation of Face Validity and Acceptability of the Care Partner Hospital Assessment Tool. [2023]
The Development and Content Validation of the Care Partner Hospital Assessment Tool. [2022]
Evaluating the Appropriateness and Feasibility of the Care Partner Hospital Assessment Tool (CHAT). [2021]
Measuring the interactions of people with dementia and their conversation partners: a preliminary adaption of the Kagan measures of support and participation in conversation. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity